No­vo Nordisk re­mains un­der UK scruti­ny as MHRA con­ducts its own re­view in 'in­cred­i­bly rare' case

3 years ago
Pharma
Marketing

Growth hor­mone from No­vo Nordisk is in short­age over man­u­fac­tur­ing de­lays

3 years ago
Pharma
Manufacturing

PhRMA calls for more di­verse in­fra­struc­ture up­grades to US emer­gency tri­als frame­work

3 years ago
Pharma

Biden signs law re­quir­ing more de­clas­si­fi­ca­tions on Covid-19's ori­gins

3 years ago
Coronavirus

Im­mat­ics an­nounces mul­ti­ple pipeline changes with lat­est fi­nan­cial re­sults

3 years ago
R&D

Mar­ket­ingRx roundup: What could a US Tik­Tok ban mean for phar­ma? Pfiz­er, Lil­ly lead phar­ma March Mad­ness ad­ver­tis­ers

3 years ago
Pharma
Marketing

Chat­G­PT with phar­ma da­ta de­buts for med­ical meet­ings, be­gin­ning with AACR

3 years ago
AI
Pharma

Roche un­veils long-term da­ta from piv­otal spinal mus­cu­lar at­ro­phy tri­al

3 years ago
R&D
Pharma

Al­tim­mune’s shares halved af­ter in­ter­im look at PhII weight loss drug da­ta

3 years ago
R&D

Af­ter rais­ing $140M, SPAC will take biotech pub­lic with a frac­tion of planned funds

3 years ago
Financing

Who are the women break­ing bar­ri­ers in drug de­vel­op­ment? Nom­i­nate them for End­points' an­nu­al re­port

3 years ago
People

In­cyte touts mid-stage da­ta for new JAK in­hibitor but stops short of se­lect­ing PhI­II dose

3 years ago
R&D

Kite's head of re­search leaves for Flag­ship start­up Sonata

3 years ago
People
Startups

Con­tra­cep­tive mak­er Evofem lets com­mer­cial chief go, cuts CEO pay 40% to save cash

3 years ago
People

One fi­nal push: EU phar­ma in­dus­try group de­mands com­pe­ti­tion check on in­com­ing leg­isla­tive over­haul

3 years ago
Pharma
Law

Karuna to raise $400M in mar­ket a day af­ter pos­i­tive read­out of schiz­o­phre­nia drug

3 years ago
Financing

So­bi's PhI­II gout win sets up a po­ten­tial ri­val­ry with fu­ture Am­gen as­set

3 years ago
R&D

A sign of what's com­ing? Pres­i­den­tial hope­ful De­San­tis tar­gets PBMs and phar­ma trans­paren­cy

3 years ago
People
Law

Mer­ck, Vi­a­tris agree to set­tle patent feud sur­round­ing di­a­betes drugs

3 years ago
Pharma
Law

Ab­b­Vie cel­e­brates decade of phar­ma work in newest cor­po­rate cam­paign

3 years ago
Pharma
Marketing

Most dos­es of No­vo Nordisk's Ozem­pic are re­moved from FDA drug short­age list af­ter sup­ply is­sues

3 years ago
Pharma
Manufacturing

Cal­i­for­nia takes an­oth­er step for­ward in its in­sulin pro­duc­tion with $50M in­vest­ment

3 years ago
Pharma
Manufacturing

FDA in­di­cates will­ing­ness to ap­prove Bio­gen ALS drug de­spite failed PhI­II study

3 years ago
R&D
FDA+

BioN­Tech to pay $200M up­front in CT­LA-4 an­ti­body de­vel­op­ment, com­mer­cial­iza­tion deal

3 years ago
Deals
First page Previous page 371372373374375376377 Next page Last page
A service from the Financial Times